Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 50 years or older.
- People who have received a clinical diagnosis of early-stage Alzheimer's disease or mild cognitive impairment (a condition where memory or thinking skills are slightly reduced), based on recognised national research guidelines.
- People who are able to understand and agree to take part in the trial on their own behalf.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with severe memory or thinking difficulties, based on a standard cognitive test score below a certain threshold (confirm with trial site).
- People who have a neurological condition that affects thinking or memory, such as a history of stroke.
- People living with a serious psychiatric (mental health) disorder.
- People who have structural abnormalities in the brain, such as tumours, that affect thinking or memory.
- People with significant vision problems.
- People who are unable to understand or communicate in Spanish.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Beta biomarkers; PTau Biomarkers; Pupil Response; Ocular vergence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.